REGENERON PHARMACEUTICALS, INC.

Est. AUM

$47.9M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Intellia Therapeutics, Inc.	Common Stock	$47.5M	3702995	99.14%	SOLE
2	Adicet Bio, Inc.	Common Stock	$412K	60511	0.86%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.